Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$883K Buy
36,687
+355
+1% +$9.29K 0.24% 44
2026
Q1
$1.02M Buy
+36,332
New +$967K 0.3% 38
2025
Q2
Sell
-8,435
Closed -$214K 117
2025
Q1
$214K Sell
8,435
-24
-0.3% -$628 0.08% 97
2024
Q4
$224K Sell
8,459
-602
-7% -$16.3K 0.08% 98
2024
Q3
$262K Sell
9,061
-4,570
-34% -$133K 0.1% 91
2024
Q2
$381K Sell
13,631
-149
-1% -$4.1K 0.16% 73
2024
Q1
$382K Sell
13,780
-801
-5% -$22.2K 0.16% 71
2023
Q4
$420K Sell
14,581
-1,226
-8% -$37.1K 0.2% 66
2023
Q3
$524K Sell
15,807
-841
-5% -$29.7K 0.27% 51
2023
Q2
$611K Buy
16,648
+1,581
+10% +$61.5K 0.31% 42
2023
Q1
$615K Sell
15,067
-13,721
-48% -$593K 0.33% 39
2022
Q4
$1.48M Buy
28,788
+2,154
+8% +$103K 0.98% 21
2022
Q3
$1.17M Buy
26,634
+1,086
+4% +$52.8K 0.87% 23
2022
Q2
$1.34M Buy
+25,548
New +$1.3M 1.05% 20

Other funds holding PFE

Joule Financial's PFE Position: Q2 2026 in Review

Joule Financial increased its Pfizer (PFE) stake by 0.98% in Q2 2026, buying an estimated $9.29K and bringing the position to 36,687 shares worth $883K. The position accounts for 0.24% of the portfolio, ranked #44.

Joule Financial first reported a position in PFE in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.48M in Q4 2022. 898 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Joule Financial held 36,687 shares of Pfizer worth $883K as of Q2 2026.
  • Joule Financial bought 355 Pfizer shares in Q2 2026, an estimated $9.29K.
  • Pfizer made up 0.24% of Joule Financial's portfolio in Q2 2026, its #44 holding.
  • Joule Financial first reported a position in Pfizer in Q2 2022 and has held it in 14 quarters since.
  • Joule Financial's Pfizer position peaked at $1.48M in Q4 2022.
  • 898 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Joule Financial's 13F filing for Q2 2026, filed 15 Jul 2026.